KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Accumulated Expenses (2016 - 2025)

Precigen (PGEN) has disclosed Accumulated Expenses for 13 consecutive years, with $10.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses rose 53.77% to $10.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.2 million, a 53.77% increase, with the full-year FY2024 number at $8.4 million, up 2.02% from a year prior.
  • Accumulated Expenses was $10.2 million for Q3 2025 at Precigen, up from $5.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $10.2 million in Q3 2025 to a low of $4.8 million in Q2 2023.
  • A 5-year average of $7.1 million and a median of $6.6 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: plummeted 37.37% in 2022, then surged 100.89% in 2024.
  • Precigen's Accumulated Expenses stood at $7.9 million in 2021, then fell by 18.83% to $6.4 million in 2022, then increased by 29.37% to $8.2 million in 2023, then rose by 2.02% to $8.4 million in 2024, then grew by 20.79% to $10.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Accumulated Expenses are $10.2 million (Q3 2025), $5.2 million (Q2 2025), and $9.6 million (Q1 2025).